Mabuprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H23NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 02B8S6J90B, chemically known as benzeneacetamide, n-(2-hydroxyethyl)-alpha-methyl-4-(2-methylpropyl)- but generally known as mabuprofen, which bears US NIH Compound Identifier 71261. European Medicines Agency schedules Mabuprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08630MIG. The term MABUPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). MABUPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mabuprofen under HS 29242995 and SITC 51479. As of Q4 2014, MABUPROFEN remains the US FDA Preferred Term for this commodity. Mabuprofen bears US NLM identifiers UMLS ID C1881504 and NCI Concept Code C66046. SMILES: O=C(NCCO)C(C1CCC(CC(C)C)CC1)C.